Product code LAN— Clinical Toxicology
ADVANCE EMIT-CAD N-ACETYLPROCAINAMIDE
- Classification name
- Enzyme Immunoassay, N-Acetylprocainamide
- Device class
- Class 2
- Regulation
- 21 CFR 862.3320
- Advisory panel
- Clinical Toxicology
- Total cleared
- 21
- First cleared
- Most recent
Market context for product code LAN
FDA has cleared devices under product code LAN between 1978 and 2006, filed by 14 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
last 15 years- 2006
- 2003
- 2001
- 1998
- 1997
- 1996
- 1993
- 1992
- 1989
- 1987
- 1986
- 1985
- 1983
- 1982
- 1978
Top applicants under product code LAN
Recent clearances under product code LAN
- K060738 — TDM N-ACETYLPROCAINAMIDE
- K032564 — DIMENSION N-ACETYLPROCAINAMIDE (NAPA) FLEX REAGENT CARTRIDGE METHOD, MODEL DF111
- K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229
- K983812 — NAPA EIA ASSAY
- K971713 — N-ACETYLPROCAINAMIDE ASSAY FOR THE BAYER IMMUNO 1 SYSTEM
- K955422 — AXSYM N-ACETYLPROCAINAMIDE
- K934705 — OPUS NAPA
- K922915 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY AND CALIBRAT
- K895571 — N-ACETYLPROCAINAMIDE (NAPA) (FPIA) KIT
- K873349 — EASY-TEST EMIT N-ACETYLPROCAINAMIDE NAPA #16649
- K871680 — MODIFIED COBAS FP REAGENTS FOR NAPA AND CALIBRATOR
- K860140 — STRATUS N-ACE (NAPA) FLUOROMETRIC ENZYME/IMMUNO.
- K853547 — STRATUS N-ACETYLPROCAINAMIDE FLUOROMETRIC ENZYME I
- K852319 — COBAS FP REAGENTS FOR NAPA AND NAPA CALIBRATORS
- K851060 — EMIT QST N-ACETYLPROCAINAMIDE ASSAY
- K833378 — N-ACETYLPROCAINAMIDE ACA-ANALYTICAL
- K832098 — N-ACETYLPROCAINAMIDE ASSAY FOR COBAS
- K831399 — AMES TDA N-ACETYL-PROCAINAMIDE TEST
- K830206 — TDX N-ACETYLPROCAINAMIDE
- K823129 — ADVANCE EMIT-CAD N-ACETYLPROCAINAMIDE
- K781378 — EMIT N-ACETYLPROCAINAMIDE ASSAY
Data sourced from openFDA. This site is unofficial and independent of the FDA.